Lombardi Comprehensive Cancer Center 3800 Reservoir Rd NW STE E501, Washington, DC 20007 202 444-2198 (phone), 202 444-7797 (fax)
Education:
Medical School Mount Sinai School of Medicine Graduated: 1977
Conditions:
Pancreatic Cancer
Languages:
English Spanish
Description:
Dr. Weiner graduated from the Mount Sinai School of Medicine in 1977. He works in Washington, DC and specializes in Medical Oncology. Dr. Weiner is affiliated with Medstar Georgetown University Hospital.
"These studies are showing there may be a path forward in solid tumors" with CAR-T therapies, said Dr. Louis Weiner, director of the Georgetown Lombardi Comprehensive Cancer Center and one of the conference leaders. It may hold promise for some cancers of the stomach, breast, colon, lung and other a
Date: Mar 31, 2019
Category: Health
Source: Google
Immune System Drugs Melt Tumors, Leading A Cancer Revolution
We are in the middle of a revolution, said Louis Weiner, of Georgetown University, at an AACR press conference about the immunotherapies. I dont think that is hyperbolic. Those are the kinds of observations that weve rarely seen in our business. What really makes it exciting is that it is not j
stimated that over 10 years, biosimilars will save up to $44 billion. As noticed by Louis Weiner, director of the Lombardi Comprehensive Cancer Center and head of the department of oncology at Georgetown University, the use of Neupogen has mostly been reduced because of the price. Thats why the aut
Date: Mar 07, 2015
Source: Google
Approval of Merck-developed melanoma drug Keytruda by FDA is a big step
"This is not a drug that attacks the cancer directly. It enables the immune system to do the job that it is capable of doing," said Louis Weiner, from Georgetown University's Lombardi Comprehensive Cancer Center. "This is the first beachhead that's been taken. It's going to be all out assault on man
Date: Sep 05, 2014
Category: Health
Source: Google
One-two vaccine punch against ovarian cancer takes center stage at AACR
Louis Weiner, MD, of Georgetown University, who was not part of the study, told reporters that the promising combination therapy promised a more effective way to treat aggressive cancers. That said, a small study like this can only offer a glimpse of a therapy's efficacy and safety, demanding furthe
Date: Apr 08, 2013
Category: Health
Source: Google
Research Shows Promise in Using Immune Therapy on Ovarian Cancer
"It's now possible to devise very efficient and complex but feasible combination strategies [starting with] a vaccination that will basically point the immune system in the direction of the tumor," said Louis Weiner, M.D. from Georgetown University. Weiner was not a part of the study. "And then you
The study "shows that it's now possible to devise very efficient and complex but feasible combination strategies (starting with) a vaccination that will basically point the immune system in the direction of the tumor," commented Louis Weiner, MD, of Georgetown University here, who was not part of th
Acting as a discussant for the studies, Louis Weiner, MD, said the findings suggest that therapies for HER2-positive breast cancer have become so effective as to render biomarkers irrelevant in some cases.